Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
PaperCitations, authors & open-access status
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 84 citations, 2024 year and hybrid oa status.
84
Citations
2024
Year
hybrid
OA Status